期刊文献+

三阴性乳腺癌危险因素及临床特征分析 被引量:14

Risk factors and clinical characteristics of triple negative breast cancer
原文传递
导出
摘要 目的探讨三阴性乳腺癌(triple negative breast cancer,TNBC)的相关危险因素及临床病理学特征。方法 210例乳腺癌患者,70例TNBC患者为观察组,140例非TNBC患者为对照组,比较2组一般资料,分析TNBC的危险因素以及临床病理学特征。结果 2组年龄、体质量指数、泌乳情况、使用避孕药以及产次比较差异均有统计学意义(P<0.05);多因素logistic回归分析显示,体质量指数>25kg/m^2(OR=9.604,95%CI:3.670~89.237,P=0.002)、抑制泌乳(OR=9.00,95%CI:1.070~75.668,P=0.043)、使用避孕药(OR=13.280,95%CI:3.322~113.423,P=0.006)是TNBC发生的危险因素;TNBC主要表现为进展期浸润性导管癌,且具有更高的T、M分期。结论肥胖、抑制泌乳以及口服避孕药是女性TNBC发生的危险因素,TNBC恶性程度高于非TNBC。 Objective To explore the risk factors and clinicopathologic characteristics of triple negative breast cancer (TNBC). Methods In 210 patients with breast cancer, there were 70 patients with TNBC (observation group) and 140 patients with other diseases (control group). The general data, risk factors and clinicopathological characteristics were analyzed in two groups. Results There were significant differences in the age, body mass index, lactation status, use of contraceptive agents and numbers of childbirth between two groups (P〈0.05). Multivariable logistic regression analysis showed body mass index 〉25 kg/m^2 (OR = 9. 604, 95% CI: 3. 670 to 89. 237, P = 0. 002), suppression of lactation (OR:9. 000, 95%CI: 1. 070 to 75. 668, P=0. 043), and the use of contraceptive agents (OR=13. 280, 95%CI: 3. 322 to 113. 423, P=0. 006) were the risk factors for TNBC. The main type of TNBC was the advanced infiltrating ductal carcinoma, with higher T and M stages. Conclusion Obesity, suppression of lactation and the use of contraceptive agents are the risk factors for TNBC. The malignant degree of TNBC is higher than non-TNBC.
出处 《中华实用诊断与治疗杂志》 2016年第11期1075-1077,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金(81501985)
关键词 三阴性乳腺癌 危险因素 临床病理学特征 Triple negative breast cancer risk factor clinicopathological characteristics
  • 相关文献

参考文献13

二级参考文献59

  • 1杨名添,戎铁华,黄植蕃,曾灿光,龙浩,傅剑华,林鹏,王欣,王思愚,王曦,唐军.可手术乳腺癌6263例临床分析[J].癌症,2005,24(3):327-331. 被引量:46
  • 2邱明,毛庆华,赵跃峰,迟宏宇.口腔鳞癌E_cadherin表达与淋巴结转移的相关性分析[J].黑龙江医药科学,2006,29(2):38-39. 被引量:7
  • 3Sorlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets[J].Proc Natl Acad Sci USA,2003,100(14):8418-8423.
  • 4Perou CM,Sorlie T,Eisen MB,et al.Molecularportraits of human breast tumours[J].Nature,2000,406(679):747-752.
  • 5Sorlie T,Perou CM,Tibshirani R,et al.Gene expression patterns ofbreast carcinomas distinguish tumor subclasses with clinical implications[J].Proc Natl Acad Sci USA,2001,98(19):10869-10874.
  • 6Foulkes WD,Stefansson IM,Chappuis PO,et al.Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer[J].Natl Cancer Inst,2003,95(19):1482-1485.
  • 7Cleator S,Heller W,Coombes RC.Triple-negative breast cancer:therapeutic options[J].Lancet Oncol,2007,8(3):235-244.
  • 8Henderson T O, Amsterdam A, Bhatia S, et al. Systermatic review: surveillance for breast cancer in women treated with chest radiation for childhood adolescent, or young adult cancer [J]. Ann Intern Med,2010,152(7):444-455.
  • 9Kulka J, Tokes A M, Toth A I. Immunohistochemical phenotype of breast carcinoma predicts the effectiveness of primary systemic therapy[J]. Magy Onko1,2009,53(4):335-343.
  • 10Wu M, Jung L, Zhou J, et al. Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model ofhuman breast cancer in mice[J]. Proc Natl Acad Sci USA, 2009, 106(17) :7022-7077.

共引文献34

同被引文献101

引证文献14

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部